☆ 4.1 Editorial Material

Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research

JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

A. Jayk Bernal et al.

Summary: This study found that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Article Medicine, General & Internal

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Jennifer Hammond et al.

Summary: In high-risk, unvaccinated adults, treatment of Covid-19 with nirmatrelvir plus ritonavir can significantly reduce the risk of hospitalization and death, with good safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Review Medicine, General & Internal

A comprehensive review of adverse events to drugs used in COVID-19 patients: Recent clinical evidence

Renato Ferreira-da-Silva et al.

Summary: This review gathered information on adverse events related to drugs used in treating COVID-19 patients. The most frequent System Organ Class (SOC) identified were investigations, skin and subcutaneous tissue disorders, nervous system disorders, infections and infestations, gastrointestinal disorders, hepatobiliary disorders, and metabolism and nutrition disorders. Further clinical studies are needed to determine the causality between these adverse events and the drugs used.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection
Editorial Material Medicine, General & Internal

The Role of Pharmacovigilance in the COVID-19 Pandemic

Renato Ferreira-Da-Silva et al.

ACTA MEDICA PORTUGUESA (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.